John J Mariani MD
Addiction
Professor of Clinical Psychiatry Columbia University Medical Center
Join to View Full Profile
51 East 25th StreetSTE 7ENew York, NY 10010
Phone+1 646-609-6771
Fax+1 646-588-1984
Dr. Mariani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York-Presbyterian HospitalFellowship, 2003 - 2005
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 2003- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Obstetrics and Gynecology, 1993 - 1995
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Obstetrics and Gynecology, 1993 - 1994
New York University School of MedicineClass of 1993
State University of New York at AlbanyBS, Biology, 1985 - 1989
Certifications & Licensure
NY State Medical License 1995 - 2026
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients Start of enrollment: 2007 Jan 01
- Study of Quetiapine Treatment for Cannabis Dependence Start of enrollment: 2009 Aug 01
- Gabapentin for Abstinence Initiation in Alcohol Dependence Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Place...Frances R Levin, John J Mariani, Martina Pavlicova, C Jean Choi, Cale Basaraba
Journal of Attention Disorders. 2024-09-01 - 2 citationsTreating Attention-Deficit/Hyperactivity Disorder Matters.Frances R Levin, Mariely Hernandez, John J Mariani
JAMA. 2024-03-12 - 2 citationsNeural correlates of drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder.Nasir H Naqvi, A Benjamin Srivastava, Juan Sanchez-Peña, Jessica K Lee, Andrew T Drysdale
Alcohol, Clinical & Experimental Research. 2024-02-01
Journal Articles
- American Psychiatric Association PublishingAdam Bisaga, Frances R Levin, John J Mariani, Maria A Sullivan, Edward V Nunes, National Institutes of Health
Press Mentions
The Non-Alcoholic’s Guide to Drinking Less AlcoholNovember 3rd, 2017
One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUDNovember 10th, 2023- One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUDNovember 18th, 2023
- Join now to see all
Grant Support
- Quetiapine Pharmacotherapy for Cannabis DependenceNational Institute on Drug Abuse2012–Present
- Pregabalin Treatment of Alcohol Use Disorder.NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2020–2024
- Gabapentin For Abstinence Initiation In Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism2010–2011
- Anticonvulsant Pharmacotherapy For Sedative-Hypnotic Use DisordersNational Institute On Drug Abuse2006–2010
Research History
- Director, Substance Treatment and Research Service (STARS) of Columbia University Medical Center Department of PsychiatryThe Substance Treatment and Research Service of Columbia University Medical Center Department of Psychiatry is a facility for conducting clinical trials evaluating potential treatments for substance use disorders and co-occurring conditions.2005 - Present
External Links
- Columbia Facultyhttp://asp.cumc.columbia.edu/facdb/profile_list.asp?uni=jm2330&DepAffil=Psychiatry
- Private Practicehttps://www.johnmarianimd.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
